001     140270
005     20240722101121.0
024 7 _ |a 10.1074/jbc.RA118.003440
|2 doi
024 7 _ |a pmid:30120199
|2 pmid
024 7 _ |a pmc:PMC6187624
|2 pmc
024 7 _ |a 0021-9258
|2 ISSN
024 7 _ |a 1067-8816
|2 ISSN
024 7 _ |a 1083-351X
|2 ISSN
024 7 _ |a altmetric:46699446
|2 altmetric
037 _ _ |a DZNE-2020-06592
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Hans, Friederike
|0 P:(DE-2719)2198927
|b 0
|e First author
|u dzne
245 _ _ |a Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43).
260 _ _ |a Bethesda, Md.
|c 2018
|b Soc.60645
264 _ 1 |3 online
|2 Crossref
|b American Society for Biochemistry & Molecular Biology (ASBMB)
|c 2018-08-17
264 _ 1 |3 print
|2 Crossref
|b American Society for Biochemistry & Molecular Biology (ASBMB)
|c 2018-10-12
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1721635866_12032
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a TAR DNA-binding protein of 43 kDa (TDP-43) forms pathological aggregates in neurodegenerative diseases, particularly in certain forms of frontotemporal dementia and amyotrophic lateral sclerosis. Pathological modifications of TDP-43 include proteolytic fragmentation, phosphorylation, and ubiquitinylation. A pathognomonic TDP-43 C-terminal fragment (CTF) spanning amino acids 193-414 contains only four lysine residues that could be potentially ubiquitinylated. Here, serial mutagenesis of these four lysines to arginine revealed that not a single residue is responsible for the ubiquitinylation of mCherry-tagged CTF. Removal of all four lysines was necessary to suppress ubiquitinylation. Interestingly, Lys-408 substitution enhanced the pathological phosphorylation of the immediately adjacent serine residues 409/410 in the context of mCherry-CTF. Thus, Lys-408 ubiquitinylation appears to hinder Ser-409/410 phosphorylation in TDP-43 CTF. However, we did not observe the same effect for full-length TDP-43. We extended the mutagenesis study to full-length TDP-43 and performed MS. Ubiquitinylated lysine residues were identified in the nuclear localization sequence (NLS; Lys-84 and Lys-95) and RNA-binding region (mostly Lys-160, Lys-181, and Lys-263). Mutagenesis of Lys-84 confirmed its importance as the major determinant for nuclear import, whereas Lys-95 mutagenesis did not significantly affect TDP-43's nucleo-cytoplasmic distribution, solubility, aggregation, and RNA-processing activities. Nevertheless, the K95A mutant had significantly reduced Ser-409/410 phosphorylation, emphasizing the suspected interplay between TDP-43 ubiquitinylation and phosphorylation. Collectively, our analysis of TDP-43 ubiquitinylation sites indicates that the NLS residues Lys-84 and Lys-95 have more prominent roles in TDP-43 function than the more C-terminal lysines and suggests a link between specific ubiquitinylation events and pathological TDP-43 phosphorylation.
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a DNA-Binding Proteins
|2 NLM Chemicals
650 _ 7 |a TDP-43 protein, human
|2 NLM Chemicals
650 _ 7 |a Ubiquitin
|2 NLM Chemicals
650 _ 7 |a Lysine
|0 K3Z4F929H6
|2 NLM Chemicals
650 _ 2 |a Active Transport, Cell Nucleus
|2 MeSH
650 _ 2 |a Cell Nucleus: metabolism
|2 MeSH
650 _ 2 |a DNA-Binding Proteins: chemistry
|2 MeSH
650 _ 2 |a DNA-Binding Proteins: genetics
|2 MeSH
650 _ 2 |a DNA-Binding Proteins: metabolism
|2 MeSH
650 _ 2 |a HEK293 Cells
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Lysine: chemistry
|2 MeSH
650 _ 2 |a Mutagenesis, Site-Directed
|2 MeSH
650 _ 2 |a Mutation
|2 MeSH
650 _ 2 |a Phosphorylation
|2 MeSH
650 _ 2 |a Protein Processing, Post-Translational
|2 MeSH
650 _ 2 |a Solubility
|2 MeSH
650 _ 2 |a Ubiquitin: metabolism
|2 MeSH
700 1 _ |a Eckert, Marita
|0 P:(DE-2719)2811929
|b 1
|u dzne
700 1 _ |a von Zweydorf, Felix
|0 P:(DE-2719)2811552
|b 2
|u dzne
700 1 _ |a Gloeckner, Christian Johannes
|0 P:(DE-2719)2811291
|b 3
|u dzne
700 1 _ |a Kahle, Philipp J
|0 P:(DE-2719)2810803
|b 4
|e Last author
|u dzne
773 1 8 |a 10.1074/jbc.ra118.003440
|b : American Society for Biochemistry & Molecular Biology (ASBMB), 2018-08-17
|n 41
|p 16083-16099
|3 journal-article
|2 Crossref
|t Journal of Biological Chemistry
|v 293
|y 2018
|x 0021-9258
773 _ _ |a 10.1074/jbc.RA118.003440
|g Vol. 293, no. 41, p. 16083 - 16099
|0 PERI:(DE-600)1474604-9
|n 41
|q 293:41<16083 - 16099
|p 16083-16099
|t The journal of biological chemistry
|v 293
|y 2018
|x 0021-9258
787 0 _ |a Gloeckner, Christian Johannes
|d PRoteomics IDEntifications Database, 2022
|i RelatedTo
|0 DZNE-2023-00188
|r
|t Mapping of TDP-43 ubiquitination and acetylation sites
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187624
909 C O |p VDB
|o oai:pub.dzne.de:140270
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2198927
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2811929
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2811552
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2811291
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2810803
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Population Studies and Genetics
|x 0
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J BIOL CHEM : 2019
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-05-04
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-05-04
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-05-04
920 1 _ |0 I:(DE-2719)1210000-4
|k AG Kahle
|l Functional Neurogenetics
|x 0
920 1 _ |0 I:(DE-2719)1210007
|k AG Gloeckner
|l Functional Neuroproteomics and Translational Biomarkers in Neurodegenerative Diseases
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210000-4
980 _ _ |a I:(DE-2719)1210007
980 _ _ |a UNRESTRICTED
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1134108
|2 Crossref
|o 10.1126/science.1134108
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.bbrc.2006.10.093
|2 Crossref
|o 10.1016/j.bbrc.2006.10.093
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2013.04.011
|2 Crossref
|o 10.1016/j.neurobiolaging.2013.04.011
999 C 5 |9 -- missing cx lookup --
|a 10.1111/jnc.13625
|2 Crossref
|o 10.1111/jnc.13625
999 C 5 |9 -- missing cx lookup --
|a 10.3389/fncel.2015.00423
|2 Crossref
|o 10.3389/fncel.2015.00423
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-008-0477-9
|2 Crossref
|o 10.1007/s00401-008-0477-9
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.21425
|2 Crossref
|o 10.1002/ana.21425
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.febslet.2008.07.027
|2 Crossref
|o 10.1016/j.febslet.2008.07.027
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00439-017-1830-7
|2 Crossref
|o 10.1007/s00439-017-1830-7
999 C 5 |9 -- missing cx lookup --
|a 10.1097/NEN.0b013e31817713b5
|2 Crossref
|o 10.1097/NEN.0b013e31817713b5
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-011-0879-y
|2 Crossref
|o 10.1007/s00401-011-0879-y
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-010-0702-1
|2 Crossref
|o 10.1007/s00401-010-0702-1
999 C 5 |9 -- missing cx lookup --
|a 10.1038/srep23281
|2 Crossref
|o 10.1038/srep23281
999 C 5 |9 -- missing cx lookup --
|a 10.1074/mcp.M800390-MCP200
|2 Crossref
|o 10.1074/mcp.M800390-MCP200
999 C 5 |9 -- missing cx lookup --
|a 10.1080/14728222.2018.1439923
|2 Crossref
|o 10.1080/14728222.2018.1439923
999 C 5 |9 -- missing cx lookup --
|a 10.1146/annurev-biochem-060310-170328
|2 Crossref
|o 10.1146/annurev-biochem-060310-170328
999 C 5 |9 -- missing cx lookup --
|a 10.1242/jcs.183954
|2 Crossref
|o 10.1242/jcs.183954
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.febslet.2015.05.040
|2 Crossref
|o 10.1016/j.febslet.2015.05.040
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0022850
|2 Crossref
|o 10.1371/journal.pone.0022850
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ng.132
|2 Crossref
|o 10.1038/ng.132
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M109.031278
|2 Crossref
|o 10.1074/jbc.M109.031278
999 C 5 |9 -- missing cx lookup --
|a 10.1083/jcb.200702115
|2 Crossref
|o 10.1083/jcb.200702115
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1471-4159.2010.07098.x
|2 Crossref
|o 10.1111/j.1471-4159.2010.07098.x
999 C 5 |9 -- missing cx lookup --
|a 10.1242/jcs.140087
|2 Crossref
|o 10.1242/jcs.140087
999 C 5 |9 -- missing cx lookup --
|a 10.1093/hmg/ddv424
|2 Crossref
|o 10.1093/hmg/ddv424
999 C 5 |9 -- missing cx lookup --
|a 10.1002/jnr.22243
|2 Crossref
|o 10.1002/jnr.22243
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neulet.2009.11.055
|2 Crossref
|o 10.1016/j.neulet.2009.11.055
999 C 5 |9 -- missing cx lookup --
|a 10.1111/jnc.12630
|2 Crossref
|o 10.1111/jnc.12630
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M114.561704
|2 Crossref
|o 10.1074/jbc.M114.561704
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0038658
|2 Crossref
|o 10.1371/journal.pone.0038658
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ncb2012
|2 Crossref
|o 10.1038/ncb2012
999 C 5 |9 -- missing cx lookup --
|a 10.2353/ajpath.2008.080003
|2 Crossref
|o 10.2353/ajpath.2008.080003
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.cell.2010.09.033
|2 Crossref
|o 10.1016/j.cell.2010.09.033
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.molcel.2011.08.025
|2 Crossref
|o 10.1016/j.molcel.2011.08.025
999 C 5 |9 -- missing cx lookup --
|a 10.1074/mcp.M111.013284
|2 Crossref
|o 10.1074/mcp.M111.013284
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awq111
|2 Crossref
|o 10.1093/brain/awq111
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M800342200
|2 Crossref
|o 10.1074/jbc.M800342200
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M111.231118
|2 Crossref
|o 10.1074/jbc.M111.231118
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12035-014-8644-6
|2 Crossref
|o 10.1007/s12035-014-8644-6
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.3421-07.2007
|2 Crossref
|o 10.1523/JNEUROSCI.3421-07.2007
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M110.197483
|2 Crossref
|o 10.1074/jbc.M110.197483
999 C 5 |9 -- missing cx lookup --
|a 10.1038/371346a0
|2 Crossref
|o 10.1038/371346a0
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.cell.2010.11.012
|2 Crossref
|o 10.1016/j.cell.2010.11.012
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0022930
|2 Crossref
|o 10.1371/journal.pone.0022930
999 C 5 |9 -- missing cx lookup --
|a 10.1007/978-1-4939-2404-2_3
|2 Crossref
|o 10.1007/978-1-4939-2404-2_3
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.brainres.2016.03.032
|2 Crossref
|o 10.1016/j.brainres.2016.03.032
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ncomms6845
|2 Crossref
|o 10.1038/ncomms6845
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.2911-10.2010
|2 Crossref
|o 10.1523/JNEUROSCI.2911-10.2010
999 C 5 |9 -- missing cx lookup --
|a 10.1186/1750-1326-5-33
|2 Crossref
|o 10.1186/1750-1326-5-33
999 C 5 |9 -- missing cx lookup --
|a 10.1093/bioinformatics/bth407
|2 Crossref
|o 10.1093/bioinformatics/bth407
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.mcn.2006.10.002
|2 Crossref
|o 10.1016/j.mcn.2006.10.002
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.molcel.2006.09.007
|2 Crossref
|o 10.1016/j.molcel.2006.09.007
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1065203
|2 Crossref
|o 10.1126/science.1065203
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0115111
|2 Crossref
|o 10.1371/journal.pone.0115111
999 C 5 |9 -- missing cx lookup --
|a 10.4172/jpb.1000091
|2 Crossref
|o 10.4172/jpb.1000091
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.molcel.2007.11.019
|2 Crossref
|o 10.1016/j.molcel.2007.11.019
999 C 5 |9 -- missing cx lookup --
|a 10.1128/MCB.01824-08
|2 Crossref
|o 10.1128/MCB.01824-08
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.ppat.1004739
|2 Crossref
|o 10.1371/journal.ppat.1004739
999 C 5 |9 -- missing cx lookup --
|a 10.1038/cdd.2009.173
|2 Crossref
|o 10.1038/cdd.2009.173
999 C 5 |9 -- missing cx lookup --
|a 10.1038/emboj.2012.261
|2 Crossref
|o 10.1038/emboj.2012.261
999 C 5 |9 -- missing cx lookup --
|a 10.1097/NEN.0b013e3181bc3bec
|2 Crossref
|o 10.1097/NEN.0b013e3181bc3bec
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2017.07.029
|2 Crossref
|o 10.1016/j.neuron.2017.07.029
999 C 5 |9 -- missing cx lookup --
|a 10.1038/s41593-017-0047-3
|2 Crossref
|o 10.1038/s41593-017-0047-3
999 C 5 |9 -- missing cx lookup --
|a 10.1038/emboj.2009.324
|2 Crossref
|o 10.1038/emboj.2009.324
999 C 5 |9 -- missing cx lookup --
|a 10.1007/978-1-60761-157-8_21
|2 Crossref
|o 10.1007/978-1-60761-157-8_21
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nmeth0608-459
|2 Crossref
|o 10.1038/nmeth0608-459
999 C 5 |9 -- missing cx lookup --
|a 10.1038/s41467-017-00088-4
|2 Crossref
|o 10.1038/s41467-017-00088-4


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21